Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: The burden of uncomplicated hospitalised cases

Vaccine

Volumn 26, Issue 44, 2008, Pages 5619-5626

  Bonanni, Paolo ^a   Boccalini, Sara ^a   Bechini, Angela ^a   Banz, Kurt ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Outcomes International   (Switzerland)

Author keywords

Decision analytic model; Economic evaluation; Hospitalisation; Vaccination; Varicella

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CHICKENPOX; CHILD; CLINICAL FEATURE; DRUG COST; DRUG EFFICACY; ECONOMIC EVALUATION; HEALTH CARE AVAILABILITY; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INFANT; INFECTION PREVENTION; INTERVENTION STUDY; ITALY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SENSITIVITY ANALYSIS; VACCINATION;

ADOLESCENT; ADULT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HERPESVIRUS 3, HUMAN; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; ITALY; MODELS, ECONOMIC; NATIONAL HEALTH PROGRAMS; VACCINATION;

EID: 52949148170     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.096     Document Type: Article

References (35)

1. Sorveglianza Pediatri Sentinella, Istituto Superiore di Sanità. Available at: http://www.spes.iss.it/.
2. Sistema Informatizzato Malattie Infettive, Istituto Superiore di Sanità. Available at: http://www.simi.iss.it/.
3. Varicella Vaccine, World Health Organization. Available at: http://www.who.int/vaccines/en/varicella.shtml.
4. National Vaccine Plan 2005-2007. Available at: http://www.ministerosalute.it/imgs/C_17_normativa_526_ulterioriallegati_ulterioreallegato_0_alleg.pdf.
5. Salmaso S., Mandolini D., Scalia Tomba G., and Esposito N. La prevenzione della varicella in Italia: strategie di vaccinazione. Ann Ig 14 4 Suppl. 6 (2002) 35-44
6. Coudeville L., Brunot A., Giaquinto C., Lucioni C., and Dervaux B. Varicella vaccination in Italy. Pharmacoecomics 22 13 (2004) 839-855
7. Thiry N., Beutels P., Tancredi F., Romano L., Zanetti A., Bonanni P., et al. An economic evaluation of varicella vaccination in Italian adolescents. Vaccine 22 (2004) 3546-3562
8. Marin M., Güris D., Chaves S.S., Schmid S., and Seward J.F. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 Jun (RR-4) (2007) 1-40
9. Kroger A.T., Atkinson W.L., Marcuse E.K., and Pickering L.K. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 RR-15 (2006) 1-48 [Erratum in: MMWR Morb Mortal Wkly Rep. 2006; 55(48):1303. MMWR Morb Mortal Wkly Rep. 2007; 56(11):256. Pediatrics. 2007; 119(5):1008]
10. New STIKO recommendation. Varicella vaccination for all. MMW Fortschr Med 146 33-34 (2004) 51
11. Banz K., Wagenpfeil S., Neiss A., Goertz A., Staginnus U., Vollmar J., et al. The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine 21 (2003) 1256-1267
12. Hammerschmidt T., Goertz A., Wagenpfeil S., Neiss A., Wutzler P., and Banz K. Validation of health economic models: the example of EVITA. Value Health 6 5 (2003) 551-559
13. Halloran M.E. Epidemiologic effects of varicella vaccination. Infect Dis Clin North Am 10 3 (1996) 631-655
14. Halloran M.E., Cochi S.L., Lieu T.A., Wharton M., and Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 140 2 (1994) 81-104
15. Lieu T., Cochi S.L., and Black S. Cost effectiveness of a routine varicella vaccination program in US children. JAMA 271 (1994) 375-381
16. Istituto Nazionale di Statistica. Available at: www.istat.it.
17. Gabutti G., Penna C., Rossi M., Salmaso S., Rota M.C., Bella A., et al. The seroepidemiology of varicella in Italy. Epidemiol Infect 126 (2001) 433-440
18. Ciofi Degli Atti M.L., Rota M.C., Mandolini D., Bella A., Gabutti G., Crovari P., et al. Assessment of varicella underreporting in Italy. Epidemiol Infect 128 (2002) 479-484
19. Beutels P., Clara R., Tormans G., Van Doorslaer E., and Van Damme P. Cost and benefit of routine varicella vaccination in German children. J Infect Dis 174 Suppl. 3 (1996) S335-S341
20. Zotti C.M., Maggiorotto G., and Migliardi A. Costs of varicella. Ann Ig 14 4 Suppl. 6 (2002) 29-33
21. Wagenpfeil S., Neiss A., Bisanz H., Wutzler P., Vollmar J., and Goertz A. Epidemiology of varicella infection to assess to burden of disease in Germany. Clin Microbiol Infect 8 Suppl. 1 (2002) 43
22. Wutzler P., Neiss A., Banz K., and Tischer A. Ist eine Elimination der Varizellen durch eine allgemeine Impfung möglich. Deutsches Ärzteblatt 15 (2002) A1024-A1029
23. Sheffer R., Segal D., Rahamani S., Dalal I., Linhart Y., Stein M., et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinica practice in Israel. Pediatr Infect Dis J 24 (2005) 434-437
24. Passwell J.H., Hemo B., Levi Y., Ramon R., Friedman N., and Lerner-Geva L. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J 23 (2004) 221-226
25. Brisson M., Edmunds W.J., Gay N.J., Law B., and De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125 3 (2000) 651-669
26. Brisson M., Edmunds W.J., Gay N.J., Law B., and De Serres G. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 18 25 (2000) 2775-2778
27. Van Damme P., and Beutels P. Economic evaluation of vaccination. Pharmacoeconomics 9 Suppl. 3 (1996) 8-15 [Discussion 23-5]
28. Norme per l'estinzione dei debiti degli enti mutualistici. Law August 17, 1974. No. 386 art. 9.
29. Fornaro P., Gandini F., Marin M., Pedrazzi C., Piccoli P., Tognetti D., et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Pediatr Infect Dis J 18 (1999) 414-419
30. Giacchino R., Losurdo G., and Castagnola E. Decline in mortality with varicella vaccination. N Engl J Med 352 17 (2005) 1819
31. Losurdo G., Bertoluzzo L., Canale F., Timitilli A., Bondi E., Castagnola E., et al. Varicella and its complications as cause of hospitalisation. Infez Med 13 4 (2005) 229-235
32. Marchetto S., de Benedictis F.M., de Martino M., Versace A., Chiappini E., Bertaine C., et al. Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era. Acta Paediatr 96 10 (2007) 1490-1493
33. Azzari C., Massai C., Poggiolesi C., Indolfi G., Spagnolo G., De Luca M., et al. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses. Curr Med Res Opin 23 12 (2007) 2945-2954
34. Kuter B., Matthews H., Shinefield H., Black S., Dennehy P., Watson B., et al. Study Group for Varivax. Ten years follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 23 2 (2004) 132-137
35. Lopez A.S., Guris D., Zimmerman L., Gladden L., Moore T., Haselow D.T., et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?. Pediatrics 117 6 (2006) e1070-e1077